Shopping Cart
- Remove All
Your shopping cart is currently empty
Atabecestat
Catalog No. T14338Cas No. 1200493-78-2
Alias RSC-385896, JNJ-54861911
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment[1].
Atabecestat
Catalog No. T14338Alias RSC-385896, JNJ-54861911Cas No. 1200493-78-2
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment[1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $132 | In Stock | |
| 5 mg | $328 | In Stock | |
| 10 mg | $529 | In Stock | |
| 25 mg | $1,060 | In Stock | |
| 50 mg | $1,420 | In Stock | |
| 100 mg | $1,920 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $363 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Atabecestat"
Phytic acid potassium
Phytic acid dipotassium salt, Inositol polyphosphate dipotassium salt, Inositol hexakisphosphate dipotassium salt, Fytic Acid dipotassium salt
T5075129832-03-7
Phytic acid dipotassium salt is an endogenous metabolite that inhibits β-secretase 1 (BACE1).
- $41
Size
QTY
Phytic acid potassium
Phytic acid dipotassium salt, Inositol polyphosphate dipotassium salt, Inositol hexakisphosphate dipotassium salt, Fytic Acid dipotassium salt
T5075129832-03-7
Phytic acid dipotassium salt is an endogenous metabolite that inhibits β-secretase 1 (BACE1).
- $41
Size
QTY
Phytic acid potassium
Phytic acid dipotassium salt, Inositol polyphosphate dipotassium salt, Inositol hexakisphosphate dipotassium salt, Fytic Acid dipotassium salt
T5075129832-03-7
Phytic acid dipotassium salt is an endogenous metabolite that inhibits β-secretase 1 (BACE1).
- $41
Size
QTY
Phytic acid potassium
Phytic acid dipotassium salt, Inositol polyphosphate dipotassium salt, Inositol hexakisphosphate dipotassium salt, Fytic Acid dipotassium salt
T5075129832-03-7
Phytic acid dipotassium salt is an endogenous metabolite that inhibits β-secretase 1 (BACE1).
- $41
Size
QTY
Auraptene
7-geranyloxycoumarin
T4115495-02-3
Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phas
- $30
Size
QTY
Auraptene
7-geranyloxycoumarin
T4115495-02-3
Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phas
- $30
Size
QTY
Auraptene
7-geranyloxycoumarin
T4115495-02-3
Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phas
- $30
Size
QTY
Verubecestat
MK-8931
T70111286770-55-5
Verubecestat (MK-8931) (MK-8931) is an effective and specific β-secretase inhibitor and β-site APP-cleaving enzyme 1 inhibitor or BACE1 protein inhibitor.
- $34
Size
QTY
Verubecestat
MK-8931
T70111286770-55-5
Verubecestat (MK-8931) (MK-8931) is an effective and specific β-secretase inhibitor and β-site APP-cleaving enzyme 1 inhibitor or BACE1 protein inhibitor.
- $34
Size
QTY
Loganin
Cited
Loganoside
T275918524-94-2
Loganin (Loganoside), an iridoid glucoside, has been reported to be an inhibitor of Cox-1 and also noted to suppress TNF-α formation. This compound also has displayed potent free-radical-scavenging activity and inhibitory effects on melanogenesis.
- $40
Size
QTY
CitedSelect Batch
Purity:99.77%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment[1]. |
| In vivo | In 5-week-old APPPS1 mice, Atabecestat (100 and 300 mg/kg; oral gavage; once daily for 3 days) reduced the levels of human Aβ1-40 and Aβ1-42 in the brain of APPPS1 mice at a dose of 300 mg/kg, and resulted in less reduction of human Aβ levels at 24 hours with a dose of 100 mg/kg[2]. |
| Alias | RSC-385896, JNJ-54861911 |
| Molecular Weight | 367.4 |
| Formula | C18H14FN5OS |
| Cas No. | 1200493-78-2 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (544.37 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Atabecestat | purchase Atabecestat | Atabecestat cost | order Atabecestat | Atabecestat chemical structure | Atabecestat in vivo | Atabecestat formula | Atabecestat molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.